American Univesity of Beirut

​​​FRAX

• WHO Global Fracture Risk Assessment Model website launched Feb 21, 2008 (More) (Key Points on FRAX) 
  

• Cancer-associated bone disease
  Rizzoli R, Body JJ, Brandi M.-L. Brandi et al. for the International Osteoporosis
  Foundation Committee of Scientific Advisors Working Group on Cancer-Induced Bone Disease (2013). Osteoporos Int 2013 DOI 10.1007/s00198-013-2530-3
• European guidance for the diagnosis and management of osteoporosis in postmenopausal women
  Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF). Osteoporos Int 2013;24(1):23-57.
• An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis
  Lekamwasam S, Adachi JD, Agnusdei D, Bilezikian J, Boonen S, Borgstrom F, Cooper C, Perez AD, Eastell R, Hofbauer LC, Kanis JA, Langdahl BL, Lesnyak O, Lorenc R, McCloskey E, Messina OD, Napoli N, Obermayer-Pietsch B, Ralston SH, Sambrook PN, Silverman S, Sosa M, Stepan J, Suppan G, Wahl DA, Compston JE; Joint IOF–ECTS GIO Guidelines Working Group. Arch Osteoporos 2012;7(1-2):25-30.
• A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis
  Lekamwasam S, Adachi JD, Agnusdei D, Bilezikian J, Boonen S, Borgstrom F, Cooper C, Diez Perez A, Eastell R, Hofbauer LC, Kanis JA, Langdahl BL, Lesnyak O, Lorenc R, McCloskey E, Messina OD, Napoli N, Obermayer-Pietsch B, Ralston SH, Sambrook PN, Silverman S, Sosa M, Stepan J, Suppan G, Wahl DA, Compston JE; Joint IOF-ECTS GIO Guidelines Working Group. Osteoporos Int 2012;23(9):2257-76.
• Osteoporosis in young adults: pathophysiology, diagnosis, and management
  Ferrari S, Bianchi ML, Eisman JA, Foldes AJ, Adami S, Wahl DA, Stepan JJ, de Vernejoul MC, Kaufman JM; IOF Committee of Scientific Advisors Working Group on Osteoporosis Pathophysiology. Osteoporos Int 2012;23(12):2735-48.
• Treatment failure in osteoporosis
  Diez-Perez A, Adachi JD, Agnusdei D, Bilezikian JP, Compston JE, Cummings SR, Eastell R, Eriksen EF, Gonzalez-Macias J, Liberman UA, Wahl DA, Seeman E, Kanis JA, Cooper C; IOF CSA Inadequate Responders Working Group. Osteoporos Int 2012;23(12):2769-74.
• Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF)
  Cooper C, Reginster JY, Cortet B, Diaz-Curiel M, Lorenc RS, Kanis JA, Rizzoli R. Curr Med Res Opin 2012;28(3):475-91.
• Frailty and sarcopenia: definitions and outcome parameters
  Cooper C, Dere W, Evans W, Kanis JA, Rizzoli R, Sayer AA, Sieber CC, Kaufman JM, Abellan van Kan G, Boonen S, Adachi J, Mitlak B, Tsouderos Y, Rolland Y, Reginster JYL. Osteoporos Int 2012;23(7):1839-48.
• Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report
  Rizzoli R, Akesson K, Bouxsein M, Kanis JA, Napoli N, Papapoulos S, Reginster JY, Cooper C. Osteoporos Int 2011;22(2):373-90.
• Towards a diagnostic and therapeutic consensus in male osteoporosis
  Kanis JA, Bianchi G, Bilezikian JP, Kaufman JM, Khosla S, Orwoll E, Seeman E; on behalf of the Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos Int 2011;22(11):2789-98.
• European guidance for the diagnosis and management of osteoporosis in postmenopausal women
  Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, Rizzoli R; European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Osteoporos Int 2008;19(4):399-428.
• Requirements for DXA for the management of osteoporosis in Europe
  Kanis JA, Johnell O. Osteoporos Int 2005;16(3):229-38.
• A new approach to the development of assessment guidelines for osteoporosis
  Kanis JA, Black D, Cooper C, Dargent P, Dawson-Hughes B, De Laet C, Delmas P, Eisman J, Johnell O, Jonsson B, Melton L, Oden A, Papapoulos S, Pols H, Rizzoli R, Silman A, Tenenhouse A; International Osteoporosis Foundation; National Osteoporosis Foundation. Osteoporos Int 2002;13(7):527-36.
• Comparison of the European and USA practice guidelines for osteoporosis
  Kanis JA, Torgerson D, Cooper C. Trends Endocrinol Metab 2000;11(1):28-32.
• An update on the diagnosis and assessment of osteoporosis with densitometry
  Kanis JA, Gluer CC; Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporos Int 2000;11(3):192-202.
• Guidelines for preclinical evaluation and clinical trials in osteoporosis. 
  WHO, Geneva. 1998.
• Guidelines for diagnosis and management of osteoporosis
  Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D. Osteoporos Int 1997;7(4):390-406.
• Quantitative ultrasound techniques for the assessment of osteoporosis: Expert agreement on current status
  Gluer CC; The International Quantitative Ultrasound Consensus Group. J Bone Miner Res 1997;12(8):1280-8.
• Practical guide for the use of bone mineral measurements in the assessment of treatment of osteoporosis: A position paper of the European Foundation for Osteoporosis and Bone Disease
  Kanis JA, Devogelaer JP, Gennari C; The Scientific Advisory Board and the Board of National Societies of the European Foundation for Osteoporosis and Bone Disease. Osteoporos Int 1996;6(3):256-61.
• Guidelines for clinical trials in osteoporosis. A position paper of the European Foundation for Osteoporosis and Bone Disease. 
  Kanis JA, Geusens P, Christiansen C. Osteoporos Int 1991;1(3):182-8.
• Consensus development conference: prophylaxis and treatment of osteoporosis.
  Osteoporos Int 1991;1(2):114-7.
• Official Positions for FRAX Clinical Regarding International Differences. From Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX.
  Cauley J, El-Hajj Fuleihan G*, Arabi A, Fujiwara S, Eis SR, Calderon A, Chionh SB, Chen Z, Curtis J, Danielson M, Hanley D, Kroger H, Kung A, Lesnyak O, Nieves J, Schott-Pethelaz AM, Pluskiewicz W, El Rassi R, Silverman S, Rizzoli R, and Luckey M, on behalf of the FRAX? Position Development Conference Members. J Clin Densitom, vol. 14, no. 3, 240e262, 2011
• Regional Report: Vitamin D widespread and on the increase in the Middle East and North Africa.International Osteoporosis Foundation 2009 (More); Press Release (More); Interview (More)
  El-Rassi R, Baliki G, and El-Hajj Fuleihan G.
  

• Official ISCD Position Statement - Adult
• Official ISCD Position Statement - Pediatric
• Links to other Guidelines/Positions
• ISCD and IOF FRAX Initiative - Official Position Statement
  

• Atypical Femur Fractures – Review of Epidemiology, Relationship to Bisphosphonates, Prevention and Clinical Management​
  Dennis M. Black, PhD, Bo Abrahamsen, MD, Mary L. Bouxsein, PhD, Thomas Einhorn,
  MD, Nicola Napoli, MD. Endocrine Reviews 2018; DOI: 10.1210/er.2018-00001.
  
• Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
  Elizabeth Shane,* David Burr,* Bo Abrahamsen, Robert A Adler, Thomas D Brown, Angela M Cheung, Felicia Cosman, Jeffrey R Curtis, Richard Dell, David W Dempster, Peter R Ebeling, Thomas A Einhorn, Harry K Genant, Piet Geusens, Klaus Klaushofer, Joseph M Lane, Fergus McKiernan, Ross McKinney, Alvin Ng, Jeri Nieves, Regis O’Keefe, Socrates Papapoulos, Tet Sen Howe, Marjolein CH van der Meulen, Robert S Weinstein, and Michael P Whyte. JBMR 2014; 29(1):1–23.
• Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Report of a Task Force of the American Society for Bone and Mineral Research
  Elizabeth Shane,* David Burr,* Peter R Ebeling, Bo Abrahamsen, Robert A Adler, Thomas D Brown, Angela M Cheung, Felicia Cosman, Jeffrey R Curtis, Richard Dell, David Dempster, Thomas A Einhorn, Harry K Genant, Piet Geusens, Klaus Klaushofer, Kenneth Koval, Joseph M Lane, Fergus McKiernan, Ross McKinney, Alvin Ng, Jeri Nieves, Regis O’Keefe, Socrates Papapoulos, Howe Tet Sen, Marjolein CH van der Meulen, Robert S Weinstein, and Michael Whyte. JBMR 2010; 25(11):2267–2294.     

• Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015
  A. Khan, A. Morrison, A. Cheung, W. Hashem, J. Compston.
• Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus 2015
  Aliya A Khan, Archie Morrison, David A Hanley, Dieter Felsenberg, Laurie K McCauley, Felice O’Ryan, Ian R Reid, Salvatore L Ruggiero, Akira Taguchi, Sotirios Tetradis, Nelson B Watts, Maria Luisa Brandi, Edmund Peters, Teresa Guise, Richard Eastell, Angela M Cheung, Suzanne N Morin, Basel Masri, Cyrus Cooper, Sarah L Morgan, Barbara Obermayer-Pietsch, Bente L Langdahl, Rana Al Dabagh, K. Shawn Davison, David L Kendler, George K Sándor, Robert G Josse, Mohit Bhandari, Mohamed El Rabbany, Dominique D Pierroz, Riad Sulimani, Deborah P Saunders, Jacques P Brown, and Juliet Compston, on behalf of the International Task Force on Osteonecrosis of the Jaw. JBMR 2015; 30(1):3–23.
• Prevention of Osteonecrosis of the Jaw (ONJ) in Patients on Bisphosphonate Therapies
  Clinical/ Patient Services - Dental/Oral, Clinical/ Patient Services - Pharmaceutical, Clinical/ Patient Services - Medical Treatment. NSW Health 2010.
• Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaw—2009 Update
  Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws: Salvatore L. Ruggiero, DMD, MD, Associate Professor, Division of Oral and Maxillofacial Surgery, Stony Brook School of Dental Medicine, Attending, Long Island Jewish Medical Center, New Hyde Park, NY, New York Center for Orthognathic and Maxillofacial Surgery, Lake Success, NY; Thomas B. Dodson. DMD, MPH, Visiting Oral and Maxillofacial Surgeon and Director, Center for Applied Clinical Investigations, Department of Oral and Maxillofacial Surgery, Massachusetts General Hospital, Associate Professor, Harvard School of Dental Medicine, Boston, MA; Leon A. Assael, DMD, Professor and Chairman, Oral and Maxillofacial Surgery, Oregon Health and Science University, Portland, OR; Regina Landesberg, DMD, PhD, Associate Professor, Columbia University, SDOS Division OMFS, New York, NY; Robert E. Marx, DDS, Professor of Surgery and Chief, Division of Oral and Maxillofacial Surgery, University of Miami School of Medicine, Miami, FL; Bhoomi Mehrotra, MD, Division of Hematology-Medical Oncology, Long Island Jewish Medical Center, New Hyde Park, NY. American Association of Oral and Maxillofacial Surgeons 2009.
• Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research
  Sundeep Khosla (Chair), David Burr, Jane Cauley, DavidWDempster, Peter R Ebeling, Dieter Felsenberg, Robert F Gagel, Vincente Gilsanz, Theresa Guise, Sreenivas Koka, Laurie K McCauley, Joan McGowan, Marc D McKee, Suresh Mohla, David G Pendrys, Lawrence G Raisz, Salvatore L Ruggiero, David M Shafer, Lillian Shum, Stuart L Silverman, Catherine H Van Poznak, Nelson Watts, Sook-Bin Woo, and Elizabeth Shane. JBMR 2007;22:1479–1491.